Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pivanex plus Docetaxel in Advanced NSCLC
NCT00073385Phase 2Completed
- Sponsor
- Titan Pharmaceuticals, Inc.
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of pivaloyloxymethyl butyrate in non-small cell lung cancer (NSCLC), sponsored by Titan Pharmaceuticals, Inc.. Started Sep 2003; status: completed.
02
Drugs
pivaloyloxymethyl butyrate
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00073385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073385.